Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Other Non-Current Liabilities (2016)

Protara Therapeutics' Other Non-Current Liabilities history spans 2 years, with the latest figure at $98000.0 for Q3 2016.

  • Quarterly Other Non-Current Liabilities rose 16.67% to $98000.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $98000.0 through Sep 2016, up 16.67% year-over-year, with the annual reading at $537000.0 for FY2015, N/A changed from the prior year.
  • Other Non-Current Liabilities came in at $98000.0 for Q3 2016, down from $241000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $537000.0 in Q4 2015 to a low of $51000.0 in Q2 2015.